ADDF, AFTD announce recipients of Frontotemporal Dementia Medication Discovery Program award The Alzheimer’s Drug Discovery Foundation and the Association for Frontotemporal Dementias announced today the recipients of their third annual research award, Frontotemporal Dementia Medication Discovery Program. The ADDF/AFTD program awarded $300,000 to three academic scientists on the leading edge of study for FTD. The award winners are: Philip Van Damme, MD, Ph.D., VIB, Leuven University ; Einar M. Sigurdsson, Ph.D., New York University School of Medication; and W. Haung Yu, Ph.D., The Taub Institute of Columbia University INFIRMARY.Garber said. AACE applauds the continuing efforts of Senator Specter to delay this flawed policy. In addition to AACE, the Specter amendment has been endorsed by many societies representing medical specialists. SOURCE American Association of Clinical Endocrinologists.
21st Century Workout Has Made ‘Aerobics’ Obsolete More than 40 12 months has passed since Dr Kenneth Cooper released the best seller reserve, ‘Aerobics’ and we’ve long since ditched the lycra, leg warmers and headbands. Dr Cooper believed that long duration activity was especially good for the most important parts of the human body, the lungs, the center and the blood vessels and would safeguard against many types of disease and illness.